Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intersect ENT Inc (NASDAQ:XENT)

17.55
Delayed Data
As of Apr 21
 -0.35 / -1.96%
Today’s Change
7.65
Today|||52-Week Range
20.64
+45.04%
Year-to-Date
No recent news for Intersect ENT Inc.

Today’s Trading

Previous close17.90
Today’s open17.85
Day’s range17.30 - 18.25
Volume275,677
Average volume (3 months)227,201
Market cap$504.7M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+12.75%
Earnings growth (this year)+11.80%
Earnings growth (next 5 years)-18.10%
Revenue growth (last year)+30.11%
P/E ratioNM
Price/Sales4.37
Price/Book4.40

Competitors

 Today’s
change
Today’s
% change
CRYCryoLife Inc+0.20+1.29%
LMATLeMaitre Vascular In...-0.23-0.91%
ANGOAngioDynamics Inc-0.23-1.46%
ATRSAntares Pharma Inc+0.06+2.17%
Data as of 4:02pm ET, 04/21/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$78.7M
Annual profit (last year)-$25.2M
Net profit margin-32.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs